Thermo Fisher Scientific (TMO) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
22 May, 2026Opening remarks and agenda
Meeting called to order with all directors, key executives, and representatives from the accounting firm and election inspector present.
Meeting commenced with instructions, followed by voting matters, management presentation, Q&A sessions, and adjournment.
Shareholders were informed of their rights to vote and submit questions virtually until the polls closed.
Board and executive committee updates
Eleven nominees for director positions were presented for election.
Chairman and CEO Marc N. Casper and Vice President and Corporate Secretary Julia L. Chen led the meeting.
Representatives from the Compensation Committee and independent auditor were introduced.
Shareholder proposals
Three proposals were presented: election of directors, advisory vote on executive compensation, and ratification of the auditor.
Voted on election of directors, advisory vote on executive compensation, and ratification of independent auditors for 2026.
Shareholders could submit questions on these proposals, which were addressed during the meeting.
Latest events from Thermo Fisher Scientific
- Targets 3–6% organic growth for 2026–2027, fueled by AI, innovation, and accretive M&A.TMO
Investor Day 202622 May 2026 - Executive compensation program revised for 2026 to enhance pay-for-performance and shareholder alignment.TMO
Proxy filing11 May 2026 - Q1 2026 delivered 6% revenue growth, 11% GAAP EPS growth, and robust segment results.TMO
Q1 20261 May 2026 - 2025 saw strong growth, major compensation changes, and continued focus on governance and ESG.TMO
Proxy filing7 Apr 2026 - Votes on directors, executive pay, and auditor ratification set for May 20, 2026 virtual meeting.TMO
Proxy filing7 Apr 2026 - Entering 2026 with strong growth, innovation, and strategic expansion across key markets.TMO
47th Annual Raymond James Institutional Investor Conference26 Mar 2026 - Targets 7%-9% organic growth, driven by innovation, M&A, and operational excellence.TMO
Investor Day 20243 Feb 2026 - Q4 revenue up 7%, EPS and free cash flow strong, with major acquisitions and innovation.TMO
Q4 20253 Feb 2026 - Q2 revenue dipped 1% but EPS grew, and guidance was raised after the Olink acquisition.TMO
Q2 20243 Feb 2026